DXCM : Insider Transactions for DexCom Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

DexCom Inc (DXCM)

$110.57

6.07 (5.2%) as of 4:30 Mon 6/24

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

389,580,000

Market Cap:

43.08(B)

Last Volume:

4,690,332

Avg Vol:

1,930,532

52 Week Range:

$75.49 - $140.45

Level I Sector:

Health Care

Level II Sector:

Health Services

Level III Sector:

Medical Instruments & Supplies

Member Indexes:

NASDAQ COMPOSITE

NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : 487

Guru Rank Value : 3

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	71,005	274,979	309,595	581,627
Total Sell Value	$9,585,020	$36,298,507	$40,264,880	$70,726,419
Total People Sold	8	10	14	16
Total Sell Transactions	13	27	50	85
End Date	2024-03-24	2023-12-22	2023-06-23	2022-06-23

Adjust Filter Settings

Records found: 2309

Page 32 of 93

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Director

– • –

2018-05-31

4

A

$0.00

$3

D/D

3,457

7,810

-

Augustinos Nicholas

Director

– • –

2018-05-31

4

A

$0.00

$3

D/D

3,457

34,472

-

Director

– • –

2018-05-31

4

A

$0.00

$4

D/D

3,695

8,348

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-05-23

4

AS

$86.00

$221,963

I/I

(2,581)

6,229

-

Gregg Terrance H

Executive Chairman

• • –

2018-05-15

4

AS

$85.90

$858,974

I/I

(10,000)

882

-

Director

– • –

2018-05-14

4

S

$88.00

$2,640,000

I/I

(30,000)

22,257

-

Director

– • –

2018-05-14

4

OE

$4.58

$137,400

I/I

30,000

52,257

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-10

4

GD

$0.00

$0

I/I

176

11,824

-

Pacelli Steven Robert

EVP, Strategy & Corp. Dev.

• – –

2018-05-10

4

OE

$7.63

$21,784

D/D

2,855

128,685

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-09

4

S

$84.77

$741,328

D/D

(8,745)

98,878

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-09

4

OE

$7.27

$85,017

D/D

8,745

99,081

-

President & CEO

• • –

2018-05-09

4

S

$84.37

$1,454,992

D/D

(17,245)

349,390

-

President & CEO

• • –

2018-05-09

4

OE

$7.63

$240,070

D/D

31,464

366,635

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-08

4

S

$85.15

$212,874

I/I

(2,500)

47,600

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-08

4

S

$84.95

$163,366

D/D

(1,923)

98,878

-

Leach Jacob Steven

SVP, Research & Development

• – –

2018-05-08

4

OE

$3.19

$6,134

D/D

1,923

100,801

-

Director

– • –

2018-05-08

4

S

$85.11

$2,678,024

I/I

(31,464)

22,257

-

Director

– • –

2018-05-08

4

OE

$7.63

$240,070

I/I

31,464

53,721

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-04-23

4

AS

$73.09

$188,649

I/I

(2,581)

8,810

-

Gregg Terrance H

Executive Chairman

• • –

2018-04-16

4

AS

$73.04

$730,414

I/I

(10,000)

882

-

Doubleday Richard

EVP, Chief Commercial Officer

• – –

2018-03-23

4

AS

$68.44

$176,643

I/I

(2,581)

11,391

-

Gregg Terrance H

Executive Chairman

• • –

2018-03-15

4

AS

$65.51

$655,122

I/I

(10,000)

10,882

-

Murphy Patrick Michael

VP, Legal Aff & Chf Compl Ofcr

• – –

2018-03-12

4

D

$60.73

$228,833

D/D

(3,768)

46,180

-

Gregg Terrance H

Executive Chairman

• • –

2018-03-12

4

D

$60.73

$605,606

D/D

(9,972)

521,674

-

EVP, Quality & Regulatory Afrs

• – –

2018-03-12

4

D

$60.73

$198,893

D/D

(3,275)

109,953

-

2309 Records found	Previous 30 31 32 33 34 35 36 37 38 39 Next	Page 32 of 93

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.